FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2301414084> ?p ?o ?g. }

• W2301414084 endingPage "18494" @default.
• W2301414084 startingPage "18485" @default.
• W2301414084 abstract "// Ming Shan 1, 2, * , Huizi Yin 1, * , Junnan Li 3 , Xiaobo Li 4 , Dong Wang 5 , Yonghui Su 1 , Ming Niu 1 , Zhenbin Zhong 1 , Ji Wang 1 , Xianyu Zhang 1 , Wenli Kang 6 , Da Pang 1, 2 1 Department of Breast Cancer Surgery, the Affiliated Tumor Hospital of Harbin Medical University, Harbin, P.R. China 2 Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, P.R. China 3 Department of Epidemiology and Biostatistics, Harbin Medical University, Harbin, P.R. China 4 Department of Pathology, Harbin Medical University, Harbin, P.R. China 5 College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, P.R. China 6 Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Headquarters, Harbin, P.R. China * These authors have contributed equally to this work Correspondence to: Da Pang, e-mail: pangda@ems.hrbmu.edu.cn Keywords: breast cancer, DNA methylation, diagnosis, MethyLight Received: December 08, 2015     Accepted: February 11, 2016     Published: February 23, 2016 ABSTRACT Detection of breast cancer at an early stage is the key for successful treatment and improvement of outcome. However the limitations of mammography are well recognized, especially for those women with premenopausal breast cancer. Novel approaches to breast cancer screening are necessary, especially in the developing world where mammography is not feasible. In this study, we examined the promoter methylation of six genes (SFN, P16, hMLH1, HOXD13, PCDHGB7 and RASSF1a) in circulating free DNA (cfDNA) extracted from serum. We used a high-throughput DNA methylation assay (MethyLight) to examine serum from 749 cases including breast cancer patients, patients with benign breast diseases and healthy women. The six-gene methylation panel test achieved 79.6% and 82.4% sensitivity with a specificity of 72.4% and 78.1% in diagnosis of breast cancer when compared with healthy and benign disease controls, respectively. Moreover, the methylation panel positive group showed significant differences in the following independent variables: ( a ) involvement of family history of tumors; ( b ) a low proliferative index, ki-67; ( c ) high ratios in luminal subtypes. Additionally the panel also complemented some breast cancer cases which were neglected by mammography or ultrasound. These data suggest that epigenetic markers in serum have potential for diagnosis of breast cancer." @default.
• W2301414084 created "2016-06-24" @default.
• W2301414084 creator A5000645986 @default.
• W2301414084 creator A5004557807 @default.
• W2301414084 creator A5010490147 @default.
• W2301414084 creator A5015060143 @default.
• W2301414084 creator A5025861271 @default.
• W2301414084 creator A5040306162 @default.
• W2301414084 creator A5046454314 @default.
• W2301414084 creator A5052014869 @default.
• W2301414084 creator A5055587956 @default.
• W2301414084 creator A5063273603 @default.
• W2301414084 creator A5067697414 @default.
• W2301414084 creator A5086855515 @default.
• W2301414084 date "2016-02-23" @default.
• W2301414084 modified "2023-09-24" @default.
• W2301414084 title "Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer" @default.
• W2301414084 cites W1552528612 @default.
• W2301414084 cites W1556996865 @default.
• W2301414084 cites W1560377790 @default.
• W2301414084 cites W1602504912 @default.
• W2301414084 cites W1658596276 @default.
• W2301414084 cites W1755052449 @default.
• W2301414084 cites W1849446486 @default.
• W2301414084 cites W1924090634 @default.
• W2301414084 cites W1929295557 @default.
• W2301414084 cites W1963853602 @default.
• W2301414084 cites W1973767578 @default.
• W2301414084 cites W1992091679 @default.
• W2301414084 cites W1995388182 @default.
• W2301414084 cites W1996342200 @default.
• W2301414084 cites W2003742874 @default.
• W2301414084 cites W2007638643 @default.
• W2301414084 cites W2010444010 @default.
• W2301414084 cites W2017439667 @default.
• W2301414084 cites W2024481416 @default.
• W2301414084 cites W2029197798 @default.
• W2301414084 cites W2043404158 @default.
• W2301414084 cites W2052674534 @default.
• W2301414084 cites W2053877457 @default.
• W2301414084 cites W2075865556 @default.
• W2301414084 cites W2077359776 @default.
• W2301414084 cites W2095708644 @default.
• W2301414084 cites W2100159406 @default.
• W2301414084 cites W2100579820 @default.
• W2301414084 cites W2102368084 @default.
• W2301414084 cites W2103673123 @default.
• W2301414084 cites W2106680700 @default.
• W2301414084 cites W2107277218 @default.
• W2301414084 cites W2108430810 @default.
• W2301414084 cites W2117457456 @default.
• W2301414084 cites W2124870706 @default.
• W2301414084 cites W2129867437 @default.
• W2301414084 cites W2134354590 @default.
• W2301414084 cites W2136655134 @default.
• W2301414084 cites W2136959508 @default.
• W2301414084 cites W2147944526 @default.
• W2301414084 cites W2153765684 @default.
• W2301414084 cites W2159845926 @default.
• W2301414084 cites W2160408484 @default.
• W2301414084 cites W2185001764 @default.
• W2301414084 cites W2192080449 @default.
• W2301414084 cites W2325332048 @default.
• W2301414084 doi "https://doi.org/10.18632/oncotarget.7608" @default.
• W2301414084 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4951303" @default.
• W2301414084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26918343" @default.
• W2301414084 hasPublicationYear "2016" @default.
• W2301414084 type Work @default.
• W2301414084 sameAs 2301414084 @default.
• W2301414084 citedByCount "83" @default.
• W2301414084 countsByYear W23014140842016 @default.
• W2301414084 countsByYear W23014140842017 @default.
• W2301414084 countsByYear W23014140842018 @default.
• W2301414084 countsByYear W23014140842019 @default.
• W2301414084 countsByYear W23014140842020 @default.
• W2301414084 countsByYear W23014140842021 @default.
• W2301414084 countsByYear W23014140842022 @default.
• W2301414084 countsByYear W23014140842023 @default.
• W2301414084 crossrefType "journal-article" @default.
• W2301414084 hasAuthorship W2301414084A5000645986 @default.
• W2301414084 hasAuthorship W2301414084A5004557807 @default.
• W2301414084 hasAuthorship W2301414084A5010490147 @default.
• W2301414084 hasAuthorship W2301414084A5015060143 @default.
• W2301414084 hasAuthorship W2301414084A5025861271 @default.
• W2301414084 hasAuthorship W2301414084A5040306162 @default.
• W2301414084 hasAuthorship W2301414084A5046454314 @default.
• W2301414084 hasAuthorship W2301414084A5052014869 @default.
• W2301414084 hasAuthorship W2301414084A5055587956 @default.
• W2301414084 hasAuthorship W2301414084A5063273603 @default.
• W2301414084 hasAuthorship W2301414084A5067697414 @default.
• W2301414084 hasAuthorship W2301414084A5086855515 @default.
• W2301414084 hasBestOaLocation W23014140841 @default.
• W2301414084 hasConcept C104317684 @default.
• W2301414084 hasConcept C107130276 @default.
• W2301414084 hasConcept C121608353 @default.
• W2301414084 hasConcept C126322002 @default.
• W2301414084 hasConcept C143998085 @default.
• W2301414084 hasConcept C150194340 @default.

• next